Few & Far Between: Conversations from the Front Lines of Drug Development

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Latest Episodes

56

July 15, 2025 00:39:28
Episode Cover

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael...

Listen

55

July 09, 2025 00:38:46
Episode Cover

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...

Listen

54

May 28, 2025 00:45:11
Episode Cover

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...

Listen

53

April 29, 2025 00:50:46
Episode Cover

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...

Listen

52

April 23, 2025 00:52:05
Episode Cover

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...

Listen

51

April 03, 2025 00:55:05
Episode Cover

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

How do you turn back the epigenetic clock for humans and their animal companions?  Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of...

Listen
Next